dacarbazine has been researched along with Hyperthyroidism in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ames, P; Boasberg, PD; Deck, R; Fournier, P; Gammon, G; Kim, H; Kristedja, TS; Martin, M; O'Day, SJ; Piro, L; Shinn, K; Wang, HJ | 1 |
1 trial(s) available for dacarbazine and Hyperthyroidism
Article | Year |
---|---|
Maintenance biotherapy for metastatic melanoma with interleukin-2 and granulocyte macrophage-colony stimulating factor improves survival for patients responding to induction concurrent biochemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Drug Eruptions; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hyperthyroidism; Immunologic Factors; Interleukin-2; Life Tables; Melanoma; Neoplasm Metastasis; Prospective Studies; Remission Induction; Survival Analysis; Tamoxifen; Thrombocytopenia; Treatment Outcome; Vinblastine | 2002 |